Johnson & Johnson Drug Company Ordered to Pay $3M for Birth Defect

Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, was ordered by a Philadelphia jury to pay $3 million for a child’s birth injuries. The jury found that the injuries occurred as a result of the mother Kelly Anderson taking Janssen drug Topomax while pregnant.

It was ruled that Janssen failed to provide adequate label information, describing the drug’s potentially harmful side-effects, including risk of physical birth defects.

In 2007, Anderson began taking Topomax to treat migraine headaches, while pregnant, unaware of its potential damages. In August of 2008, her child was born with a bilateral cleft palate and lip. Since then, the child has required four surgeries and 14 overall procedures to correct the problem.

In general, the drug is prescribed to prevent migraine headaches and certain types of seizures in adults. The Antiepileptic Drug Pregnancy Registry reports that children exposed to Topomax within the first trimester have a 3.8 percent prevalence of oral birth defects. In 2011, the U.S. Food and Drug Administration required Janssen Pharmaceuticals update the Topomax drug information label.

If you or someone you know has been injured due to medical malpractice or a bad drug, contact a lawyer who may be able to get you compensated for your losses. The lawyers at Cohen Placitella & Roth PC have distinguished themselves as proven leaders in medical malpractice litigation and have won multi-million dollar recoveries in a variety of these suits. We invite you to contact Chris Placitella, Esq., today for a consultation at 888-375-7600 and discuss your case.



Comments are closed.

Product Safety News

Top Practice Areas

Mesothelioma, Medical Malpractice, Birth Injury, Spinal Cord Injury, Failure to Diagnose Cancer, Cerebral Palsy, Brain Injury, Personal Injury, Car Accidents, Truck Accidents

New Jersey
Birth Injury, Medical Malpractice, Mesothelioma, Personal Injury, Car Accidents, Truck Accidents

Cohen, Placitella & Roth, P.C.